Before You Invest In Neurocrine Biosciences Inc. (NASDAQ:NBIX), Consider This Metric

In yesterday’s Wall Street session, Neurocrine Biosciences Inc. (NASDAQ:NBIX) shares traded at $104.14, up 0.68% from the previous session. As of this writing, 26 analysts cover Neurocrine Biosciences Inc. (NASDAQ:NBIX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $150.00 and a […]